Phase I Study of MK-1775 with Radiation and Temozolomide In Patients with Newly Diagnosed Glioblastoma and Evaluation of lntratumoral Drug Distribution in Patients with Recurrent Glioblastoma

Grant

Date/time Interval

  • November 1, 2013 - December 31, 2020

    • Awarded By

    Total Award Amount

  • 12000.00

    • Direct Costs

  • 8164.00

    • Sponsor Award Id

  • ABTC1202

    • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Rhodemarie Maron   Investigator  
  • Xiaosi Han   Investigator